Interplay among cardiotrophin‐1, prostaglandins, and vascular endothelial growth factor in rat liver regeneration†
Open Access
- 18 February 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 41 (3) , 460-469
- https://doi.org/10.1002/hep.20590
Abstract
Prostaglandins are hepatoprotective molecules generated in liver regeneration by the rapid induction of cyclooxygenase‐2 (COX‐2). Cardiotrophin‐1 (CT‐1) and vascular endothelial growth factor (VEGF) are other hepatoprotective mediators upregulated at 24 hours after partial hepatectomy. The interactions among these molecules during liver regeneration have not yet been defined. Here we show that rats subjected to partial hepatectomy treated with NS‐398, a specific COX‐2 inhibitor, exhibited cell cycle arrest, increased hepatocyte apoptosis, persistent extracellular signal‐regulated kinase (ERK) 1/2 activation, and increased interleukin‐6 production. These changes were associated with downregulation of CT‐1 and COX‐1 and altered pattern of VEGF expression. Administration of an adenovirus encoding CT‐1 to NS‐398‐treated rats restituted normal levels of COX‐1, prostaglandins, and VEGF in the liver after partial hepatectomy and restored normal liver regeneration. Furthermore, the stimulation of isolated rat hepatocytes with CT‐1 increased COX‐1, COX‐2, and VEGF messenger RNAs and prostaglandin synthesis. Conversely, the addition of prostaglandin E1 to the culture increased CT‐1 and VEGF production. In conclusion, COX‐2 activation and production of prostaglandins soon after partial hepatectomy are essential requirements for hepatocyte proliferation and for the correct induction of both CT‐1 and VEGF. CT‐1 can restore liver regeneration after COX‐2 inhibition by increasing VEGF, COX‐1 expression, and prostaglandin synthesis. (HEPATOLOGY 2005;41:460–469.)Keywords
Funding Information
- Ministerio de Sanidad y Consumo (01/723)
- Gobierno de Navarra
- Instituto de Salud Carlos III (C02/03)
- FIS (01/0723)
- FIMA (Foundation for Applied Medical Research)
This publication has 43 references indexed in Scilit:
- Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cellsHepatology, 2002
- Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2 and Bcl-xL proteinsOncogene, 2002
- High Intensity ERK Signal Mediates Hepatocyte Growth Factor-induced Proliferation Inhibition of the Human Hepatocellular Carcinoma Cell Line HepG2Journal of Biological Chemistry, 2001
- Vascular Endothelial Growth Factor and Angiopoietin in Liver RegenerationBiochemical and Biophysical Research Communications, 2001
- PGE2 Stimulates VEGF Expression in Endothelial Cells via ERK2/JNK1 Signaling PathwaysBiochemical and Biophysical Research Communications, 2001
- Contribution of cyclooxygenase‐2 to liver regeneration after partial hepatectomyThe FASEB Journal, 2001
- TNF-alpha dependent production of inducible nitric oxide is involved in PGE1 protection against acute liver injuryGut, 2000
- Prostaglandins Up-Regulate Vascular Endothelial Growth Factor Production through Distinct Pathways in Differentiated U937 CellsBiochemical and Biophysical Research Communications, 2000
- Liver regenerationJournal of Hepatology, 2000
- Effect of prostaglandin E1 on experimental acute hepatic failure in rabbits: prostaglandin E1 prevents the development of multiple-organ failureJournal of Hepatology, 1994